Avingtrans PLC

Avingtrans PLC exhibits a capital structure with a debt-to-equity ratio of 0.23, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.6, suggesting it can cover short-term obligations but with limited surplus. However, the company's free cash flow is negative at -1.93 million GBP, and capital expenditures are -14.29 million GBP, indicating ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 5.8% and a return on assets (ROA) of 3.4%, both below the industry median for Industrial Machinery & Equipment firms. The company's gross profit margin is 31.7%, while the operating margin is 5.1%, reflecting moderate efficiency in converting revenue to profit. The company's revenue is distributed across two primary segments: Energy Advanced Engineering Systems (AES) and Medical & Industrial Imaging (MII). The AES division operates in the energy sector, while the MII division focuses on medical and industrial imaging systems. No specific geographic revenue breakdown is provided, but the company has operations in the UK, US, China, and India. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year (FY) outlook is not explicitly provided, but the company's revenue history shows a total of 156.41 million GBP in the latest reporting period. The risk assessment indicates a low dilution potential, with no significant dilution expected in the near term. However, the company's net cash position is negative after subtracting total debt, which could impact its financial flexibility. Recent events include the publication of the latest financial snapshot and risk assessment, which highlight the company's liquidity and profitability challenges. Analysts have provided price targets ranging from 681.00 to 770.00, with a mean recommendation of 1.50, indicating a generally positive outlook.